Healthcare Global Enterprises Ltd
Next 500 2024
+ 6 More
+ 6 More
Share
Share
OVERVIEW
FINANCIALS
About
Healthcare Global Enterprises Ltd. (HCG) is India's largest provider of cancer care, managing a network of comprehensive cancer centers across the country. The company offers advanced diagnostics and treatment options, including radiation therapy, medical oncology, and surgical oncology. HCG's focus on research and personalized care has made it a leader in oncology services in India.
Incorporation Year: 1998
Headquarters: Bengaluru, Karnataka, India
Top Management: Dr. B.S. Ajaikumar (Executive Chairman)
Industry: Healthcare - Ancillary
Website: hcgel.com
Featured In Fortune India Ranking
Next 500 India
#328(2024)#219(2023)#255(2022)#214(2021)#321(2020)#317(2019)#448(2018)
#328(2024)#219(2023)#255(2022)#214(2021)#321(2020)#317(2019)#448(2018)
Financial Data 2024
Revenue
1,937
(INR Cr)
Net Operating Income
1,908
(INR Cr)
Assets
2,188
(INR Cr)
Profit
48
(INR Cr)
Net Worth
826
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1937 12.9% | 1716 9.5% | 1566 51.5% | 1034 -5.9% | 1099 11.1% | 989 13.8% | 869 21.6% | 715 21.7% | 587 11.3% | 528 15.4% | 457 33.4% | 343 26.1% | 272 24.6% | 218 223.3% | 68 - |
| Net Operating Income (INR Cr) | 1908 12.80% | 1691 21.27% | 1395 38.21% | 1009 -7.61% | 1092 11.92% | 976 17.77% | 829 18.38% | 700 19.85% | 584 12.47% | 519 15.08% | 451 33.41% | 338 26.91% | 267 24.09% | 215 0.00% | 66 0.00% |
| Profit (INR Cr) | 48 64.1% | 29 -45.4% | 54 - | -193 - | -107 - | -25 - | 21 -7.4% | 22 - | -1 - | 1 - | -36 - | -11 - | -3 - | 6 - | -10 - |
| Assets (INR Cr) | 2188 20.2% | 1820 -0.8% | 1834 6.2% | 1728 -8.0% | 1878 51.1% | 1243 6.1% | 1172 17.6% | 997 16.2% | 858 30.6% | 657 13.6% | 578 -6.8% | 620 38.0% | 449 43.4% | 313 97.9% | 158 - |
| Net Worth (INR Cr) | 826 -4.0% | 861 -1.1% | 870 24.8% | 697 82.9% | 381 -20.0% | 477 -7.5% | 515 19.1% | 433 1.6% | 426 52.4% | 279 6.0% | 264 -6.9% | 283 34.2% | 211 23.5% | 171 0.0% | 135 0.0% |
| Employee Cost (INR Cr) | 308 12.0% | 275 17.8% | 234 19.3% | 196 -5.8% | 208 12.7% | 185 17.0% | 158 29.3% | 122 21.3% | 101 23.3% | 82 6.2% | 77 43.6% | 53 26.9% | 42 30.6% | 32 232.1% | 10 - |
| Interest Cost (INR Cr) | 109 | 104 | 98 | 119 | 138 | 70 | 42 | 23 | 38 | 34 | 32 | 29 | 24 | 14 | 1 |
| Cash & Bank Balance (INR Cr) | 303 | 197 | 198 | 41 | 32 | 21 | 29 | 85 | 58 | 27 | 25 | 11 | 17 | 6 | 2 |
| Total Debt (INR Cr) | 1274 | 901 | 915 | 977 | 1347 | 658 | 464 | 420 | 324 | 349 | 292 | 308 | 217 | 134 | 23 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 2.5% | 1.7% | 3.4% | - | - | - | 2.4% | 3.1% | - | 0.2% | - | - | - | 2.9% | - |
| Profit As % Of Assets | 2.2% | 1.6% | 2.9% | - | - | - | 1.8% | 2.2% | - | 0.1% | - | - | - | 2.0% | - |
| Profit As % Of Networth | 5.8% | 3.4% | 6.2% | - | - | - | 4.0% | 5.1% | - | 0.3% | - | - | - | 3.7% | - |
| Interest Cost to EBITDA % | 33.4% | 35.0% | 54.9% | 523.8% | 87.9% | 62.7% | 39.3% | 21.9% | 48.7% | 47.8% | 85.3% | 63.1% | 58.2% | 35.9% | - |
| Debt to Equity Ratio | 1.54 | 1.05 | 1.05 | 1.40 | 3.53 | 1.38 | 0.90 | 0.97 | 0.76 | 1.25 | 1.11 | 1.09 | 1.03 | 0.78 | 0.17 |
| RONW | 3.1% | 1.4% | -0.6% | - | - | - | 1.9% | 4.0% | - | 1.3% | - | - | - | 4.1% | - |
| ROCE | 7.2% | 6.6% | 4.6% | 0.0% | 0.0% | 0.0% | 5.0% | 5.6% | 5.5% | 6.8% | 0.0% | 0.0% | 5.6% | 7.0% | 0.0% |